Zimmer Biomet beats top-line and bottom-line estimates; initiates FY26 outlook and new stock repurchase authorization
Source: SeekingAlpha
2026-02-10 06:35:05 ET
More on Zimmer Biomet
- Zimmer Biomet Holdings, Inc. (ZBH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Zimmer Biomet: Execution Remains The Sticking Point
- Zimmer Biomet Holdings, Inc. (ZBH) Presents at Jefferies London Healthcare Conference 2025 Transcript
- Zimmer Biomet Q4 2025 Earnings Preview
- Zimmer Biomet drops after cautious remarks on outlook
Read the full article on Seeking Alpha
For further details see:
Zimmer Biomet beats top-line and bottom-line estimates; initiates FY26 outlook and new stock repurchase authorization
Zimmer Biomet Holdings Inc.
NASDAQ: ZBH
ZBH Trading
0.51% G/L:
$93.11 Last:
406,196 Volume:
$92.49 Open:
ZBH Latest News
February 25, 2026 07:06:00 am
Zimmer Biomet to Release New Data, Highlight Key Innovations at American Academy of Orthopaedic Surgeons Annual Meeting
February 10, 2026 06:30:00 am
Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results
ZBH Stock Data
$18,267,384,832
196,199,739
0.04%
469
N/A
Medical Equipment & Supplies
Healthcare
US
Warsaw
